Delivery Order SPE2DB22D9367-SPE2DB25FSY51
Award Date 6/18/25
Potential Completion Date 7/11/25
Potential Value $15K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc. on September 11, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine formulation used for surgical site infiltration and nerve block anesthesia. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, will be delivered to Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $37,659.45 to DMS Pharmaceutical Group Inc. for EXPAREL 266 mg/20 mL vials. The order was issued on September 11, 2025, with an ultimate completion date of October 2, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency awarded a $25.1K delivery order to DMS Pharmaceutical Group Inc. on July 21, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine product used for infiltration and nerve block anesthesia in surgical settings. This delivery order is issued without a set-aside designation and carries an ultimate completion date of August 11, 2025, under a firm fixed-price arrangement. The work will be performed in Park Ridge, Illinois, where DMS...
- The Defense Logistics Agency awarded a delivery order valued at $25,106.30 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials on August 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 19, 2025, will be fulfilled from the vendor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,107.10 to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. This delivery order represents a firm fixed-price contract with an ultimate completion date of September 30, 2025, and will be fulfilled from the vendor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an...
- The Defense Logistics Agency awarded a delivery order valued at $2,510.63 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. EXPAREL is a liposomal bupivacaine formulation used for local anesthesia and post-operative pain management in surgical settings. The contract utilizes firm fixed-price pricing and carries an ultimate completion date of August 21, 2025. This delivery order...
- The Defense Logistics Agency awarded a $20,085.04 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 30, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. This award carries an ultimate completion date of August 20, 2025, and will be performed in Park Ridge, Illinois. No set-aside designation was applied to this contract. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois, was selected as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $4,521.66 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL 133mg/10ml (10 units). The award was issued on August 7, 2025, with an ultimate completion date of August 26, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery from its Park Ridge location. This delivery order carries no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $15,063.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order was awarded on August 12, 2025, with an ultimate completion date of September 3, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, valued at $15,063.78 with an ultimate completion date of October 9, 2025, was issued without a set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the federal pharmaceutical supply...